Page last updated: 2024-08-23
paclitaxel and cd 437
paclitaxel has been researched along with cd 437 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kumar, A; Parekh, HK; Soprano, DR | 1 |
| Garattini, E; Gianni', M; Terao, M | 1 |
Other Studies
2 other study(ies) available for paclitaxel and cd 437
| Article | Year |
|---|---|
Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Topics: Antineoplastic Agents; Blotting, Northern; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Paclitaxel; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Tumor Cells, Cultured | 2001 |
Correspondence re: A. Kumar et al., cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res., 61: 7552-7555, 2001.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Paclitaxel; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids | 2002 |